Continuing Medical Education (CME)
The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
All of our active CME/MOC Part II courses are now located on our online education platform.
2025 LIVE WEBINARS
February 19, 8pm Eastern Time
The Aerodigestive Patient Presenting with Reflux
February 26, 8pm Eastern Time
Culinary Medicine: Milk Protein Allergy/Lactose Intolerance
March 5, 8pm Eastern Time
Crafting New Horizons: Blending Art, Medicine and Novel Techniques in Intestinal Rehabilitation and Transplantation
April 16, 8pm Eastern Time
Writing the Best Manuscript Possible
ON DEMAND WEBINARS
Advances in Pediatric Endoscopic Modalities for GI Motility Disorders
Pediatric endoscopy has revolutionized the way we diagnose and treat NGM disorders in children. Although PNGM disorders are prevalent, remarkable progress has been made in the last decade. Novel modalities such as functional lumen imaging probe, per-oral endoscopic myotomy (POEM), gastric-POEM and electrocautery incisional therapy have changed the diagnostic and therapeutic landscape of PNGM. Access to these modalities remains limited, and there is a lack of awareness on the indications and feasibility of these techniques. This webinar aims to increase that awareness, and raise of level of understanding on when to utilize the advanced modalities in order to improve patients’ outcomes and quality of life.
Joint NASPGHAN PASPGHAN Webinar - Celiac Disease: Current Guidelines and Practice Realities on Both Sides of the Atlantic.
Debate on Diagnostic Strategies: To Biopsy or Not To Biopsy?
What to do with Difficult Cases: Practice Management and Patient Follow Up
Navigating Endoscopic Procedure Complications
Endoscopic procedures in pediatric patients can result in a unique set of challenges and complications. This webinar will bring in-depth knowledge and practical strategies for preventing, identifying and managing key complications such as perforation, bleeding and post-polypectomy issues, along with expert guidance on managing stricture dilation in young patients. Don’t miss this opportunity to advance your expertise in the dynamic and delicate field of pediatric gastrointestinal care.
Navigating the Rapidly Changing Landscape of EoE Treatment
The last two years have seen rapid advancement in therapy options for EoE, moving beyond dietary elimination, off-label use of proton pump inhibitors and swallowed topical steroids. In May of 2022, dupilumab became the first FDA approved medication for EoE in patients 12 years and older, and January 2024 brought approval for ages 1-11. Next came the first and only oral medication approved for EoE - budesonide oral suspension EOHILIA. These changes have resulted in questions around best approaches and practices in treating EoE patients. Our webinar will deliver a particular focus on new medication options for pediatric patients with EoE as well as challenges faced by clinicians and patients.
Emerging Trends in Pediatric Esophageal Dysphagia
There are multiple causes for esophageal dysphagia in children – some are congenital while others are acquired – and addressing swallowing issues in pediatric patients requires a comprehensive approach. It is vital for providers to understand the clinical presentations associated with these conditions.
Join Emerging Trends in Pediatric Esophageal Dysphagia to hear our expert panel discuss the full range of diagnostic modalities available, the appropriate timing for endoscopy, diagnostic techniques such as EndoFlip and the different treatment options for dysphagia based on its underlying etiology.
Supported by an educational grant from Medtronic.
Children diagnosed with FAPDs are more likely to have decreased quality of life and to develop psychiatric or psychological comorbidities. Vital to the clinical success of the patient is both the patient and the family’s understanding and belief in the diagnosis.
This webinar will bring you a detailed discussion on the importance of often overlooked factors, including the important role of the patient-provider relationship, identifying and navigating impactful family dynamics and the role of an integrative therapeutic approach that all have a significant impact on clinical outcomes.
Pediatric gastroenterologists are frequent users of technology, but most practitioners use existing offerings provided to them by the hospital.
This webinar will provide an understanding of the process to evaluate new technology, describe the basics of developing a business plan, explain the concept of healthcare value in evaluating new technology and understanding the reimbursement/coding plan the new device or technology would utilize.
Supported through educations grants from EvoEndo, Medtronic and Neuraxis.
Current Concepts in Pediatric Dysphagia: Oropharyngeal, Esophageal and the Extremes
Pediatric dysphagia, or difficulty swallowing, affects children ages 3 to 17 in the United States. While there are four phases of the physiologic swallow, clinicians frequently evaluate and manage symptoms associated with the oropharyngeal and esophageal phases.
There are numerous possible diagnoses that may contribute to dysphagia and its sequelae, and therefore effectively navigating the investigative process can be challenging.
The development of new diagnostic techniques have shown to be beneficial in recognizing underlying pathophysiology, in addition to identifying new diagnoses.
Current Concepts in Pediatric Dysphagia: Oropharyngeal, Esophageal and the Extremes aims to provide a detailed discussion on the novel diagnostic techniques and therapeutic management of these disorders, including supragastric belching and retrograde cricopharyngeal dysfunction.
Navigating the Rapidly Changing Landscape of EoE Treatment
The last two years have seen rapid advancement in therapy options for EoE, moving beyond dietary elimination, off-label use of proton pump inhibitors and swallowed topical steroids. In May of 2022, dupilumab became the first FDA approved medication for EoE in patients 12 years and older, and January 2024 brought approval for ages 1-11. Next came the first and only oral medication approved for EoE - budesonide oral suspension EOHILIA. These changes have resulted in questions around best approaches and practices in treating EoE patients. Our webinar will deliver a particular focus on new medication options for pediatric patients with EoE as well as challenges faced by clinicians and patients.
Please visit NASPGHAN's new on line learning center (NASPGHAN Learn on Line) for all CME and MOC Part II activities regarding webinars (live and on demand), and the following:
NASPGHAN Nutrition Curriculum for Pediatric GI Fellows
The ABC's of EGIDs On Line Learning Modules
On Demand Webinars
- Pediatric Multidisciplinary Aerodigestive Care: The Role of the Gastroenterologist in the Management of Aerodigestive Symptomatology
- Practical Tips in the Nutritional Management of Children with Cholestatic Liver Disorders, supported by educational grants from Mirum Pharmaceuticals and Albireo Pharma, Inc. *please not credit is not offered for this program
- EGIDs: Beyond the Esophagus, supported by an educational grant from Allakos
- Pediatric Multidisciplinary Aerodigestive Care: The Role of the Gastroenterologist in the Management of Aerodigestive Symptomatology
- Long-term Central Venous Access Management in Pediatric Intestinal Failure, supported by an educational grant from Fresenius Kabi
- NASPGHAN APPSPGHAN Joint Webinar *please note credit is not offered for this program
- Integrating QI Into Your Practice and Career, (Webinar Wednesday)
- Updating Parenteral Nutrition: Now and the Future, supported by an educational grant from Fresenius Kabi
- Teaching and Technology: Great or Glitz , (Webinar Wednesday)
- Update on Alternative Lipids, supported by an educational grant from Fresenius Kabi
- Advances in Diagnosis and Treatment of Alagille Syndrome, supported by educational grants from Mirum Pharmaceuticals, Albireo and Retrophin
- Changing the Dynamic: How to Enable EHRs to Work for You (Members, only), (Webinar Wednesday)
- Latest Guidance on Parenteral Nutrition, supported by an educational grant from Fresenius Kabi
- Nutritional Management of Children with Cholestatic Liver Diseases *please note credit is not offered for this program
- Telehealth: Practice Management, supported by educational grants from Abbott Nutrition, Takeda Pharmaceuticals, Inc., Gerber Products Company, Mead Johnson Nutrition, Nutricia North America, Inc. and Innovative Health Solutions
- Telehealth: Technical Issues, Documentation and Billing, supported by educational grants from Abbott Nutrition, Takeda Pharmaceuticals, Inc., Gerber Products Company, Mead Johnson Nutrition, Nutricia North America, Inc. and Innovative Health Solutions
- Transnasal Endoscopy: Going Where We Have Never Gone Before, supported by an educational grant from Olympus
- New Frontiers in Intestinal Failure: The Latest and Greatest
- Liver Disease in ZSD *please note credit is not offered for this program
- Nutrition Considerations in PBD-ZSD * please note credit is not offered for this program
Other Resources
Nutrition Pearls
Bowel Sounds Podcasts